US Sleep Apnea Devices Market worth $4.54 billion by 2031
The report "US Sleep Apnea Devices Market by Product [Therapeutic {PAP (CPAP, APAP, BPAP), Oral Appliances, Masks}, Diagnostic {PSG, Home Sleep Testing, Oximeter}], Age, Gender, End User [Sleep Clinics, Hospitals, Home Care Settings] – Forecast to 2031", is projected to reach USD 4.54 billion by 2031 from USD 3.11 billion in 2026, at a CAGR of 7.8% during the forecast period.
Browse 130 market data Tables and 59 Figures spread through 200 Pages and in-depth TOC on "US Sleep Apnea Devices Market by Product [Therapeutic {PAP (CPAP, APAP, BPAP), Oral Appliances, Masks}, Diagnostic {PSG, Home Sleep Testing, Oximeter}], Age, Gender, End User [Sleep Clinics, Hospitals, Home Care Settings] – Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/united-states-sleep-apnea-devices-market-220821026.html
The US sleep apnea devices market has experienced notable growth, driven by rising demand for home sleep testing solutions. These solutions offer patients a convenient and effective way to diagnose sleep disorders. Furthermore, the rise of digital health solutions has attracted significant attention for addressing challenges in the US market. However, patient adherence to CPAP treatment remains low, which may slightly hinder market growth. On a positive note, innovative developments in sleep apnea treatment devices and improved comfort in mask designs are likely to enhance patient compliance and drive overall growth in the US market.
Home care settings segment led the US sleep apnea devices market in 2025
The US sleep apnea devices market is segmented into home care settings, hospitals, sleep clinics, ambulatory care centers, primary care facilities, and other end users. Among these, home care settings are the leading segment due to the increasing demand for at-home diagnosis and treatment of sleep apnea. This approach reduces the need for patients to seek care in a hospital or sleep clinic. The comfort provided by home sleep tests and CPAP therapy devices has significantly contributed to market growth. Additionally, the rising demand for convenient access to treatment has further propelled the expansion of the US sleep apnea devices market, particularly in the home care settings segment.
In 2025, the therapeutic devices segment accounted for the largest share of the US sleep apnea devices market.
The market comprises both therapeutic and diagnostic devices, with therapeutic solutions holding a larger share, particularly in continuous disease management. This segment leads the market due to ongoing technological innovations in PAP systems and mask interfaces, which enhance patient comfort and ease of use, thereby improving therapy adherence. Key companies providing innovative, patient-centered solutions in this market include ResMed (US), Philips (Netherlands), and Fisher & Paykel Healthcare (New Zealand), all of which maintain strong positions in the US sleep apnea devices market.
The key players in the US sleep apnea devices market include Philips (Netherlands), ResMed (US), Inspire Medical Systems (US), Fisher & Paykel Healthcare (New Zealand), Compumedics Limited (Australia), SomnoMed (Australia), and ProSomnus Sleep Technologies (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the US Sleep Apnea Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
